Science

Shankar Siva: PSMA PET Sensitivity Surpasses 90% in Prostate Cancer Meta-Analysis

Shankar Siva/iconcancercentre.com.au

May 21, 2025, 08:27

Shankar Siva: PSMA PET Sensitivity Surpasses 90% in Prostate Cancer Meta-Analysis

Shankar Siva, Radiation Oncologist at Peter MacCallum Cancer Centre, shared a post on X:

“This might just be THE DEFINITIVE meta-analysis of PSMA PET for prostate cancer recurrence.

Meta-analysis of 43 studies (n=8,119)

Sensitivity from 48% at PSA 0.2–0.5 ng/ml to >90% at PSA >2.

Congrats Declan Murphy, Marlon Perera and team European Association of Urology (EAU)!”

Title: The Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Assessment of Local Recurrence and Distant Metastases in Patients with Biochemical Recurrence of Prostate Cancer After Definitive Treatment: A Systematic Review and Meta-analysis

Authors: Elio Mazzone, Alice Thomson, David C. Chen, Donato Cannoletta, Leonardo Quarta, Antony Pellegrino, Giorgio Gandaglia, Daniel Moon, Renu Eapen, Nathan Lawrentschuk, Francesco Montorsi, Shankar Siva, Michael S. Hofman, Arturo Chiti, Alberto Briganti, Marlon L. Perera, Declan G. Murphy

Read Full Article.

PSMA PET

Read an Article about Immunotherapy for Prostate Cancer on OncoDaily.

Alberto Briganti Alice Thomson Antony Pellegrino Arturo Chiti cancer Daniel Moon David C. Chen Declan G. Murphy Donato Cannoletta Elio Mazzone Francesco Montorsi Giorgio Gandaglia Leonardo Quarta Marlon L. Perera Michael S Hofman Nathan Lawrentschuk OncoDaily Oncology Renu Eapen Shankar Siva

Top 10 Oncogrants of the Week: Advancing Breakthroughs in Cancer Care

Solange Peters Honored with the IASLC Paul A. Bunn, Jr. Scientific Award 2025

World Radiotherapy Awareness Day, September 7: Recognizing the Hidden Hero of Cancer Care

16 Posts Not to Miss From WCLC 2025 Part 1

Aparna Parikh Has Been Named Program Director for the GI Medical Oncology Program at Mass General Brigham